Midwestern Adult Communication Disorders Group
Your Subtitle text



lease use the links below for information on upcoming MACDG events

Current event:             

Central Nervous System (CNS) Manifestations of Alzheimer’s disease and COVID-19: 2021 Clinical and Research

Virtual Conference/Webinar via Zoom
Wednesday April 28th, 2021

Registration and Conference from 5:30-8:30 on Zoom™

Presenter: Dr. David B. Carr, MD

Dr. Carr is the Alan A. and Edith L. Wolff Professor of Geriatric Medicine in the Department of Medicine and Neurology at
Washington University at St. Louis.  Dr. Carr is a clinician in the Memory Diagnostic Center and Geriatric Assessment Clinic at WU 
where he maintains an outpatient consulting practice in dementia and geriatric care.  He is involved in Alzheimer's disease drug
trials and is a site PI in the Graduate Trial and the Green Memory Trial in WU Alzheimer's Treatment Unit.  He has been and currently is the principal investigator or co-investigator on research, national guidelines, and/or educational initiatives related to 
medical conditions and driving with funding through NIA, NEI, Missouri Department of Transportation, and Missouri Foundation
for Health.  He also has been active in consulting work with NHTSA, TIRF, University of Toronto, Medscape, Up-to-date and the 
American Geriatric Society.  He has been the primary author or co-author on over 100 peer-reviewed manuscripts and chapters, most related to older drivers.  
Overview of the Webinar:

Dr. Carr will be presenting for the duration of the conference, presenting information related to neurological deficits within the
central nervous system following COVID-19 diagnosis for those who have Alzheimer's disease.  The presentation will provide insight and clinical education as to how clinicians can utilize biomarkers to diagnose/determine dementia and severity.  This info
rmation will be relevant to the practice of Speech-Language Pathologists in a variety of settings, as well as OT, PT, and other health care professionals.  
This course is being offered for 3 MSHA clock hours.  
*PTs, OTs and other health care professions attending will receive a certificate of attendance.

Learner Objectives

Participants will be able to:

1. Know how to diagnose dementia and are able to utilize Alzheimer’s disease (AD) biomarkers in diagnosing the disease.

2. Understand and am knowledgeable on the latest research efforts on treating Alzheimer’s disease.

3. Possess knowledge on the central nervous system (CNS) manifestations of SARS-CoV-2.

4. Understand and utilize the research efforts to improve persistent symptoms related to SARS-CoV-2.


*Please Note: We are only able to host the first 100 people that sign up*

Thank you so much!  We look forward to connecting with you soon!